Home » Topics » BioWorld Science

BioWorld Science
RSS

REXGEX trial shows importance of immune status for enhanced efficacy with CetuGEX

May 29, 2018

FDA grants priority review for gilteritinib NDA in relapsed or refractory AML

May 29, 2018

IDMC recommends continuation of phase III study of Zepsyre in small cell lung cancer

May 29, 2018

FDA approves Cimzia for the treatment of adults with moderate to severe plaque psoriasis

May 29, 2018

Arroyo BioSciences' AB-22 granted U.S. orphan drug designation for IPF

May 29, 2018

Tazemetostat granted U.S. orphan drug designation for chordoma

May 29, 2018

FDA grants orphan drug designation to SNX-5422 for neuroendocrine tumors

May 29, 2018

ImmuPharma releases further data analysis from pivotal trial of Lupuzor in SLE

May 29, 2018

JCR obtains approval in Brazil to begin phase II trial of JR-141 for Hunter's syndrome

May 29, 2018

AB Science offers update on European MAA for masitinib in ALS

May 29, 2018

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...